What’s happened.

Most medical device companies are built with a buyer in mind: prove the clinical efficacy, then hand the technology to a larger firm with the distribution muscle to take it to market. Intellijoint Surgical’s founders expected the same. “We thought that within eight months we were all going to be millionaires and would figure out life from there,” co-founder and CTO Andre Hladio told BetaKit. “That was 16 years ago.”

The Kitchener-Waterloo company began as a fourth-year capstone project in the University of Waterloo’s mechatronics engineering program, where Armen Bakirtzian, Richard Fanson and Hladio set out to help surgeons align implants more accurately during joint replacements. They founded Intellijoint in 2010, earned a Health Canada Device Medical Licence for Intellijoint HIP in 2013, and saw the product used for the first time that same year at Mount Sinai Hospital in Toronto. The company has since expanded into pre-operative surgical planning and intraoperative navigation for both hip and knee replacements, with the founders spending years inside operating rooms alongside the surgeons using the technology. “We are not doing this simply to make other people wealthy,” Hladio said. “We are doing it to create value for ourselves, our community, and the stakeholders around us.”

That choice carries a commercial cost that rarely gets discussed. A company that sells to a strategic acquirer never has to build a category story, a referenceable clinical evidence base presented for buyers rather than regulators, or a demand engine that reaches surgeons and procurement committees directly. A company that stays independent has to build all three, and has to sustain them for years rather than until a term sheet arrives.

What it means for your business.

If your plan is to own your distribution rather than hand it to an acquirer, your marketing has to do work that an exit-track company can defer indefinitely: establishing the category, carrying the evidence, and generating demand in your own name. The independence decision is as much a go-to-market commitment as a financial one, and it is worth costing out as such.

Explore this opportunity for your business

Sources & context.

Reported developments are separated from MKTGSpace’s suggested commercial next steps. Reconfirm current conditions before acting.

See where you fit.

Tell us what you sell. We will come prepared to discuss where your offer fits, who to reach and the marketing strategy and implementation needed to pursue the opportunity.

Apply this to my business